Company intelligence / Profile preview

Polymerase Capital

Palo Alto, California, United Statesgenascence.com ↗

Ownership: Private
Development stage: Other

Overview

Polymerase Capital is a venture capital firm that invests in early-stage life science and biotechnology companies. It has led or participated in seed and Series A rounds for companies such as Genascence, which develops gene therapies for musculoskeletal diseases. The firm’s partners include experienced scientists and entrepreneurs with backgrounds in molecular biology, genetics, and advanced biologics.

Industry: Investors

Partnerships

Invested in Genascence alongside DeepWork Capital and University of Florida Research Foundation

Beyond the preview

Go deeper on Polymerase Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polymerase Capital.

Explore the full profile